Floatz logo

69 assets in Kidney Cancer

Therapeutic assets addressing Kidney Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Girentuximab
Kidney Cancer
Memorial Sloan Kettering Cancer CenterP3BB (70)
Lenvatinib
Kidney Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (67)
Adriamycin
Kidney Cancer
Oliver JonasP3BB (66)
Axitinib
Kidney Cancer
Stephanie BergP4BB (66)
Cabozantinib
Kidney Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (66)
Catequentinib
Kidney Cancer
Fudan UniversityP3BB (66)
Cyclophosphamide
Kidney Cancer
Oliver JonasP3BB (66)
Nivolumab
Kidney Cancer
Guliz OzgunP4BB (66)
Carboplatin
Kidney Cancer
Oliver JonasP3BB (65)
Ipilimumab
Kidney Cancer
Guliz OzgunP4BB (65)
Pembrolizumab
Kidney Cancer
Essen BiotechP4BB (65)
Dexasone
Kidney Cancer
TakedaP2BB (64)
Everolimus
Kidney Cancer
Fudan UniversityP3BB (64)
Capecitabine
Kidney Cancer
Oliver JonasP2B (62)
Irinotecan
Kidney Cancer
M.D. Anderson Cancer CenterP3B (62)
Tislelizumab
Kidney Cancer
Fudan UniversityP3B (62)
Benmelstobart
Kidney Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P3B (60)
Durvalumab
Kidney Cancer
Ajjai Alva, MDP2B (60)
Pazopanib
Kidney Cancer
Sun Yat-sen UniversityP3B (60)
Toripalimab
Kidney Cancer
West China HospitalP2B (60)
Atorvastatin
Kidney Cancer
Tampere University HospitalP3B (59)
Polyethylene Glycol 3350
Kidney Cancer
Chad R. TracyP4B (59)
Belzutifan
Kidney Cancer
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)P2CCC (55)
Olaparib
Kidney Cancer
Oliver JonasP2CCC (55)
NKT2152
Kidney Cancer
NiKang Therapeutics, Inc.P2CCC (54)
Teonanacatl
Kidney Cancer
Psyence Australia Pty LtdP2CCC (53)
Glutamine
Kidney Cancer
University of Texas Southwestern Medical CenterP2CCC (52)
Casdatifan
Kidney Cancer
Dana-Farber Cancer InstituteP2CCC (51)
Hydromorphon
Kidney Cancer
University of MiamiP2CCC (51)
Ibuprofen
Kidney Cancer
University of MiamiP2CCC (51)
Ivocizumab
Kidney Cancer
Fudan UniversityP2CCC (51)
Ketorolac
Kidney Cancer
University of MiamiP2CCC (51)
Oxycodone
Kidney Cancer
University of MiamiP2CCC (51)
Palbociclib
Kidney Cancer
Stephanie BergP2CCC (51)
Ursodeoxycholic Acid
Kidney Cancer
Jinling Hospital, ChinaP2CCC (51)
Vipivotide Tetraxetan
Kidney Cancer
Dana-Farber Cancer InstituteP2CCC (51)
Zimberelimab
Kidney Cancer
Dana-Farber Cancer InstituteP2CCC (51)
Guadecitabine
Kidney Cancer
Ajjai Alva, MDP1/2CCC (48)
Acarbose
Kidney Cancer
University of Alabama at BirminghamP2CC (47)
3-(2,2,2-TRIMETHYLDIAZANIUMYL)PROPANOATE
Kidney Cancer
Kidney Cancer Research BureauP1/2CC (46)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Kidney Cancer
Kineta Inc.P1/2CC (46)
[212pb]vmt-alpha-net
Kidney Cancer
National Cancer Institute (NCI)P1CC (43)
a2b395
Kidney Cancer
A2 Biotherapeutics Inc.P1/2CC (43)
Alintegimod
Kidney Cancer
7 Hills Pharma, LLCP1/2CC (43)
Ebnk-001
Kidney Cancer
Essen BiotechP1/2CC (43)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Kidney Cancer
Sensei Biotherapeutics, Inc.P1/2CC (43)
Interleukin-15
Kidney Cancer
Essen BiotechP1/2CC (43)
Oxodotreotide
Kidney Cancer
National Cancer Institute (NCI)P1CC (43)
Solnerstotug
Kidney Cancer
Sensei Biotherapeutics, Inc.P1/2CC (43)
Tak-500
Kidney Cancer
TakedaP1/2CC (43)
Showing 1 to 50 of 69 assets
PreviousPage 1 of 2Next